Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

How effective is S-1 maintenance chemotherapy for patients with advanced non-small cell lung cancer?

How effective is S-1 maintenance chemotherapy for patients with advanced non-small cell lung cancer?

Posted by on Jun 25, 2020 in Lung cancer | 0 comments

In a nutshell This study examined how effective S-1 (Teysuno) chemotherapy is for patients with advanced non-small cell lung cancer (NSCLC) following initial chemotherapy treatment. The results showed that S-1 improved patients’ survival without NSCLC worsening but increased the number of side effects. Some background Treatment for patients...

Read More

Can biological drug pembrolizumab added to chemotherapy improve treatment results long-term for patients with non-small cell lung cancer?

Can biological drug pembrolizumab added to chemotherapy improve treatment results long-term for patients with non-small cell lung cancer?

Posted by on Jun 13, 2020 in Lung cancer | 0 comments

In a nutshell This study examined if the addition of pembrolizumab (Keytruda) to chemotherapy with pemetrexed (Alimta) and platinum improved treatment results long-term for patients with advanced non-small-cell lung cancer (NSCLC). The authors found that patients who received pembrolizumab with chemotherapy had improved survival and...

Read More

Can pembrolizumab combined with chemotherapy slow the progression of extensive stage small-cell lung cancer?

Can pembrolizumab combined with chemotherapy slow the progression of extensive stage small-cell lung cancer?

Posted by on Jun 10, 2020 in Lung cancer | 0 comments

In a nutshell The study evaluated the addition of pembrolizumab (Keytruda) to etoposide (Etopophos) and platinum chemotherapy drugs for patients with untreated extensive-stage (ES) small-cell lung cancer (SCLC). The study found that pembrolizumab improved progression-free survival (PFS; survival without cancer getting worse) when added to...

Read More

Does chemotherapy and SBRT improve survival in older patients with early stage non-small cell lung cancer (NSCLC)?

Does chemotherapy and SBRT improve survival in older patients with early stage non-small cell lung cancer (NSCLC)?

Posted by on Jun 7, 2020 in Lung cancer | 0 comments

In a nutshell This study investigated chemotherapy (CT) and stereotactic body radiotherapy (SBRT) in older patients with early-stage non-small cell lung cancer (NSCLC). They found that CT after SBRT improved survival in older patients with tumors greater than 4 cm. Some background Non-small cell lung cancer (NSCLC) is the most common form of lung...

Read More

Can specialized imaging techniques improve how chemo-radiotherapy is administered in locally advanced non-small cell lung cancer?

Posted by on Apr 21, 2020 in Lung cancer | 0 comments

In a nutshell This study set out to compare conventional-dose chemoradiotherapy (CRT) to reduced CRT based on 18F-FDG PET in locally advanced non-small cell lung cancer (NSCLC). The investigators found that 18F-FDG PET-based CRT improved tumor control without increasing side effects in these patients.  Some background NSCLC accounts for...

Read More

Can antibiotics and proton pump inhibitors alter the effectiveness of treatment for patients with non-small cell lung cancer?

Posted by on Apr 21, 2020 in Lung cancer | 0 comments

In a nutshell This study examined the effects of antibiotics or proton pump inhibitor (PPI) drugs on treatment for patients with non-small cell lung cancer (NSCLC). The authors found that both antibiotics and PPIs reduced the effectiveness of biological therapy but not chemotherapy. Some background Not all patients with NSCLC respond to...

Read More

What gut-related side effects do immunotherapy drugs and chemotherapy cause patients with cancer?

Posted by on Apr 14, 2020 in Lung cancer | 0 comments

In a nutshell This study examined if certain immunotherapy drugs increased the risk of developing side effects in the gut in patients with cancer also receiving chemotherapy. The results showed that immunotherapy drugs increased the risks of developing gut-related side effects compared to chemotherapy alone. Some background Immunotherapy drugs that...

Read More

Do biological drugs work better alone or in combination with other drugs for patients with advanced non-small cell lung cancer who previously received treatment?

Posted by on Apr 7, 2020 in Lung cancer | 0 comments

In a nutshell This study compared if anti-PD-1 biological drugs were more effective alone or when used with other drugs to treat patients with advanced non-small cell lung cancer who had previously received treatment. The results showed that the combination of anti-PD-1 and other drugs such as chemotherapy improved patients’ survival more than...

Read More